Afferent pupillary defect is predictor of vision survival
October 1st 2008All patients presenting with open-globe injuries should be treated as aggressively as possible, but a recent study shows that the presence of an afferent pupillary defect is the best indicator of permanent visual loss in these patients.
Beyond anti-VEGF: Investigative drugs, approaches abound
October 1st 2008Drugs are under development and in clinical trials that can complement anti-vascular endothelial growth factor drugs (VEGF) and attack age-related macular degeneration in ways that differ from the anti-VEGF approach. If these prove successful, many more patients can benefit from therapy for AMD.
Prepare for hyperopic shift following DSAEK graft surgery
October 1st 2008A retrospective study including 45 eyes that underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) found an average refractive change of +0.88 D after surgery. That hyperopic shift after DSAEK has implications for management of patients undergoing cataract surgery simultaneously with or after DSAEK and for anticipating refractive outcomes in pseudophakic patients undergoing DSAEK.
Court: J&J, Ocular Insight settle over contact lens ad claims
September 18th 2008In response to a complaint filed in July by Johnson & Johnson Vision Care Inc., a U.S. district court in New York has ordered Ocular Insight Inc. to discontinue permanently stating or communicating in its advertising, promotional materials, or activities for the company's contact lenses (Clear 58) in the United States any of the following claims:
Audio Coverage from Day 4 of the ESCRS Congress
September 17th 2008In today's podcast, Rudy M.M.A. Nuijts, MD, PhD, compares DSEK with PK and discusses the future of therapeutic corneal surgery. Also, James McCulley, MD, discusses the newest generation of a fully pre-loaded IOL delivery system, and Günther Grabner, talks about whether the differences in femtosecond lasers have any clinical significance.
Femtosecond to fully replace microkeratome
September 16th 2008The age of microkeratomes is coming to an end as femtosecond lasers come of age. That's the chief conclusion drawn by Dr Gunther Grabner, professor of ophthalmology at the Paracelsus University of Salzburg, in a survey on the advantages and limitations of femtosecond lasers.
Dry eye diagnostic coming to a clinic near you
September 16th 2008OcuSense, makers of the innovative TearLab Osmolarity System for the diagnosis of dry eye, announced the signing of multi-year agreements with four distributors in five EU countries, for the exclusive distribution of the TearLab system.
Understanding unhappiness post-LASIK provides basis for optimizing care
September 16th 2008Results of a review of patients dissatisfied with LASIK who presented for consultation to a tertiary care center suggest that ophthalmologists should obtain a thorough medical history before surgery, particularly in regard to dry eye.
Frame vendors: your most important bond
September 15th 2008Nearly 100 top-tier frame vendors are in the marketplace, vying for your frame dollars. Consider 10 key traits before collaborating with a frame vendor and its representative; you’ll increase the odds for a long-term, prosperous business relationship.
7EYE, Winter Wildlands Alliance team to preserve public land for snowsports
September 15th 2008Enhancing its commitment to the environment, 7EYE has partnered with the Winter Wildlands Alliance (WWA), a Boise, ID-based non-profit organization promoting the preservation of winter wildlands and a quality human-powered snowsports experience on public lands.
Crystallized contact lense cases to help raise breast cancer awareness
September 15th 2008Bausch & Lomb continues its commitment to raising awareness of breast cancer by giving away 40 limited edition pink Crystallized Swarovski Elements contact lens cases in an online contest during October, which is Breast Cancer Awareness Month.